RT @FrontCellDevBio: New Research: The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy:…
1,859 followers
3,894 followers
New Research: The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy: In the era of immune checkpoint blockade cancer therapy, cytokines have become an attractive immune therapeutics to… https://t.co/jfejLv7
38 followers
Our paper demonstrates MOA of PK-optimized IL21 as a new cancer immunotherapy. Increased DC1 numbers and CD8 memory. Potential combination with multiple immune checkpoint inhibitors. https://t.co/neTqIOkAXo